In the face of growing demand for healthcare, you’re tasked with the quadruple aim of improving patient experiences, clinician experiences, and business outcomes while lowering overall costs. With the constant evolution of how services are delivered, you need healthcare technology that helps you achieve these goals. With early detection, 95% of vision loss caused by diabetic retinopathy can be prevented, but patient compliance with annual retinal exams is about 60%.1 Patients often find it difficult to obtain an annual diabetic retinal exam for several reasons: lack of insurance or healthcare access, limited knowledge of the risk, or cultural and language barriers.
Implementing a diabetic retinopathy solution for primary care such as the RetinaVue care delivery model can help healthcare providers increase patient access to diabetic retinal exams in primary healthcare settings to help improve patient outcomes and lower population healthcare costs.
Baxter, RetinaVue and Welch Allyn are trademarks of Baxter International Inc. or its subsidiaries.
Azure and Microsoft are trademarks of Microsoft Corporation.
US-FLC147-240148 (v1.0) 11/2024